Takeda Pharmaceutical (TAK) Total Liabilities: 2018-2025

  • Takeda Pharmaceutical's Total Liabilities fell 9.34% to $47.9 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $47.9 billion, marking a year-over-year decrease of 9.34%. This contributed to the annual value of $48.0 billion for FY2025, which is 11.64% down from last year.
  • Latest data reveals that Takeda Pharmaceutical reported Total Liabilities of $47.9 billion as of Q1 2025, which was down 9.34% from $52.9 billion recorded in Q1 2024.
  • Takeda Pharmaceutical's 5-year Total Liabilities high stood at $73.1 billion for Q1 2021, and its period low was $47.9 billion during Q1 2025.
  • Moreover, its 3-year median value for Total Liabilities was $52.9 billion (2024), whereas its average is $52.8 billion.
  • Data for Takeda Pharmaceutical's Total Liabilities shows a maximum YoY declined of 11.75% (in 2022) over the last 5 years.
  • Over the past 5 years, Takeda Pharmaceutical's Total Liabilities (Quarterly) stood at $73.1 billion in 2021, then declined by 11.75% to $64.5 billion in 2022, then declined by 10.87% to $57.5 billion in 2023, then fell by 8.02% to $52.9 billion in 2024, then declined by 9.34% to $47.9 billion in 2025.
  • Its Total Liabilities stands at $47.9 billion for Q1 2025, versus $52.9 billion for Q1 2024 and $57.5 billion for Q1 2023.